ViroGates A/S (VIRO.CO)

DKK 7.0

(1.74%)

EBITDA Summary of ViroGates A/S

ViroGates A/S's latest annual EBITDA in 2023 was -12.48 Million DKK , down -18.28% from previous year.
ViroGates A/S's latest quarterly EBITDA in 2024 Q2 was -4.21 Million DKK , down -13.61% from previous quarter.
ViroGates A/S reported an annual EBITDA of -10.58 Million DKK in 2022, up 42.93% from previous year.
ViroGates A/S reported an annual EBITDA of -18.57 Million DKK in 2021, up 4.69% from previous year.
ViroGates A/S reported a quarterly EBITDA of -3.71 Million DKK for 2024 Q1, down -16.49% from previous quarter.
ViroGates A/S reported a quarterly EBITDA of N/A for 2023 FY, down -18.28% from previous quarter.

Annual EBITDA Chart of ViroGates A/S (2023 - 2015)

Historical Annual EBITDA of ViroGates A/S (2023 - 2015)

Year	EBITDA	EBITDA Growth
2023	-12.48 Million DKK	-18.28%
2022	-10.58 Million DKK	42.93%
2021	-18.57 Million DKK	4.69%
2020	-19.5 Million DKK	0.66%
2019	-19.59 Million DKK	-9.0%
2018	-17.96 Million DKK	-137.38%
2017	-7.57 Million DKK	-10.75%
2016	-6.83 Million DKK	-30.1%
2015	-5.25 Million DKK	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-4.21 Million DKK	-13.61%
2024 Q1	-3.71 Million DKK	-16.49%
2023 FY	- DKK	-18.28%
2023 Q3	-2.19 Million DKK	43.19%
2023 Q1	-3.24 Million DKK	-74.54%
2023 Q2	-3.86 Million DKK	-19.15%
2023 Q4	-3.18 Million DKK	-45.01%
2022 Q1	-3.37 Million DKK	21.12%
2022 FY	- DKK	42.93%
2022 Q4	-1.85 Million DKK	43.16%
2022 Q3	-3.26 Million DKK	-56.49%
2022 Q2	-2.08 Million DKK	38.05%
2021 Q2	-5.23 Million DKK	-15.5%
2021 Q1	-4.53 Million DKK	3.14%
2021 FY	- DKK	4.69%
2021 Q4	-4.27 Million DKK	5.08%
2021 Q3	-4.5 Million DKK	14.01%
2020 Q3	-3.91 Million DKK	13.06%
2020 Q1	-5.57 Million DKK	19.95%
2020 Q4	-4.68 Million DKK	-19.62%
2020 Q2	-4.5 Million DKK	19.23%
2020 FY	- DKK	0.66%
2019 Q2	-4.56 Million DKK	-19.04%
2019 FY	- DKK	-9.0%
2019 Q4	-6.96 Million DKK	-64.34%
2019 Q3	-4.23 Million DKK	7.13%
2019 Q1	-3.83 Million DKK	54.02%
2018 Q4	-8.33 Million DKK	-203.94%
2018 Q3	-2.74 Million DKK	-375.5%
2018 Q1	-2.71 Million DKK	-48.24%
2018 Q2	995.43 Thousand DKK	136.65%
2018 FY	- DKK	-137.38%
2017 Q1	-1.27 Million DKK	0.0%
2017 Q3	-1.84 Million DKK	29.45%
2017 Q2	-2.61 Million DKK	-105.35%
2017 FY	- DKK	-10.75%
2017 Q4	-1.83 Million DKK	0.82%
2016 FY	- DKK	-30.1%
2015 FY	- DKK	0.0%

Peer EBITDA Comparison of ViroGates A/S

Name	EBITDA	EBITDA Difference
Ambu A/S	691 Million DKK	101.806%
ChemoMetec A/S	193.97 Million DKK	106.434%
Demant A/S	5.21 Billion DKK	100.239%
GN Store Nord A/S	2.31 Billion DKK	100.54%
Scandinavian Medical Solutions A/S	21.22 Million DKK	158.802%